Suppository Drug Delivery Is Making a Comeback

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Suppository Drug Delivery Is Making a Comeback

YouTube video thumbnail

In this episode of Bio Break, Nick and Nigel explore one of the oldest and most underappreciated drug delivery methods in modern medicine: the suppository. While often the subject of light humor, suppository drug delivery is gaining serious attention in the MedTech world for its effectiveness, ease of use, and broad applicability.

What Makes Suppositories Effective?

Suppositories are an example of non-oral drug delivery that bypasses the gastrointestinal system’s complex environment. Unlike oral tablets, which are subject to breakdown in the stomach and first-pass metabolism in the liver, suppositories can deliver medication directly into the bloodstream. This can lead to faster onset of action and greater bioavailability for certain drugs.

They’re particularly useful in scenarios where oral administration isn’t practical—such as when a patient is unconscious, vomiting, or otherwise unable to swallow medication. For these cases, suppository drug delivery provides a reliable and safe alternative.

Versatility in Drug Delivery

Suppositories are well-known for treating localized issues like hemorrhoids and constipation, but their role in systemic delivery is expanding. The slow-melting base at body temperature enables steady absorption, which can be ideal for sustained-release applications.

Nick and Nigel highlight the growing interest in advanced formulations like liposomes, nanoparticles, and mucoadhesives. These allow for more targeted delivery, longer duration of action, and better retention in mucosal tissues. Some formulations use thermosensitive materials that stay solid at room temperature but activate upon insertion—further enhancing delivery control.

A Resurgent Interest

According to Nick, the market for suppository-based drug delivery is growing, supported by promising research and real clinical needs. With an estimated 10% annual growth rate, this method is proving its value in both emerging therapies and everyday healthcare.

While suppositories may seem elementary, they continue to evolve—offering a reliable, low-cost solution in the right therapeutic context.

Learn more about StarFish Medical.

Two people seated at a table holding handheld medical device prototypes, with text overlay reading "Is It Ready for a Human?" — MedDevice by Design episode on clinical prototypes for human use

Clinical Prototypes for Human Use: What You Need to Know

Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.

Nick and Nigel each holding a different USPTO patent certificate, illustrating the difference between a design patent and a utility patent in a Bio Break episode

Design Patent vs Utility Patent: What’s the Difference?

In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.

Mickey Urdea and Scott Phillips headshots for MedTech Unscripted exit strategy webinar

Built for Exit: What Drives MedTech Success

Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.

Gloved technician handling sterile medical device packages during V&V sample testing

MD+DI: Medical Device V&V Cost and Timeline Explained

Nigel Syrotuck breaks down the realistic medical device V&V cost and schedule for terminally sterilized devices, picking up after design freeze and walking through each major phase of the process.